[go: up one dir, main page]

AU2998300A - Genetically altered mesenchymal stem cells and methods of use thereof - Google Patents

Genetically altered mesenchymal stem cells and methods of use thereof

Info

Publication number
AU2998300A
AU2998300A AU29983/00A AU2998300A AU2998300A AU 2998300 A AU2998300 A AU 2998300A AU 29983/00 A AU29983/00 A AU 29983/00A AU 2998300 A AU2998300 A AU 2998300A AU 2998300 A AU2998300 A AU 2998300A
Authority
AU
Australia
Prior art keywords
methods
stem cells
mesenchymal stem
genetically altered
altered mesenchymal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU29983/00A
Inventor
David Geis
Elliott A. Gruskin
Nabil Tawil
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United States Surgical Corp
Original Assignee
United States Surgical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United States Surgical Corp filed Critical United States Surgical Corp
Publication of AU2998300A publication Critical patent/AU2998300A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU29983/00A 1999-02-17 2000-02-16 Genetically altered mesenchymal stem cells and methods of use thereof Withdrawn AU2998300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12045299P 1999-02-17 1999-02-17
US60120452 1999-02-17
PCT/US2000/003963 WO2000049136A1 (en) 1999-02-17 2000-02-16 Genetically altered mesenchymal stem cells and methods of use thereof

Publications (1)

Publication Number Publication Date
AU2998300A true AU2998300A (en) 2000-09-04

Family

ID=22390389

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29983/00A Withdrawn AU2998300A (en) 1999-02-17 2000-02-16 Genetically altered mesenchymal stem cells and methods of use thereof

Country Status (2)

Country Link
AU (1) AU2998300A (en)
WO (1) WO2000049136A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR047712A1 (en) 2002-09-07 2006-02-15 Royal Veterinary College TREATMENT METHOD OF A NATURAL SOFT SKELETTIC TISSUE INJURY MANAGING A COMPOSITION OF MESENQUIMATOSE MOTHER CELLS
JP2007530543A (en) 2004-03-22 2007-11-01 オシリス セラピューティクス，インコーポレイテッド Mesenchymal stem cells and use thereof
US9598673B2 (en) 2006-05-19 2017-03-21 Creative Medical Health Treatment of disc degenerative disease
US8745680B2 (en) 2007-01-06 2014-06-03 At&T Intellectual Property I, Lp Techniques for call integration with a television set-top box (STB)
WO2010033285A2 (en) * 2008-06-26 2010-03-25 Spectrum Health Method for treating and preventing radiation damage using genetically modified mesenchymal stem cells
GB0820492D0 (en) 2008-11-07 2008-12-17 Sportcell Cell compositions and uses thereof
US9420770B2 (en) 2009-12-01 2016-08-23 Indiana University Research & Technology Corporation Methods of modulating thrombocytopenia and modified transgenic pigs
EP4663241A2 (en) 2010-10-08 2025-12-17 Mesoblast International Sàrl Enhanced msc preparations
WO2016015007A1 (en) 2014-07-25 2016-01-28 Recellerate, Inc. Methods of treating exercise-induced pulmonary hemorrhage
CN112004923A (en) 2017-11-22 2020-11-27 迈索布拉斯特国际有限公司 Cell compositions and methods of treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2237089T3 (en) * 1998-03-13 2005-07-16 Osiris Therapeutics, Inc. USES FOR NON-AUTOMATIC HUMAN MESENQUIMATE MOTHER CELLS
CA2328524A1 (en) * 1998-05-29 1999-12-02 Osiris Therapeutics, Inc. Human cd45+ and/or fibroblast + mesenchymal stem cells

Also Published As

Publication number Publication date
WO2000049136A1 (en) 2000-08-24

Similar Documents

Publication Publication Date Title
AU2730497A (en) Cryopreservation and extensive subculturing of human mesenchymal stem cells
AU4055600A (en) Impaction substrate and methods of use
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
IL145002A0 (en) Adipose-derived stem cells and lattices
IL144359A0 (en) Immortalized cell lines and methods of making the same
AU1939801A (en) In situ bioreactors and methods of use thereof
IL149933A0 (en) Pancreatic stem cells and their use in transplantation
AU8128094A (en) (in vitro) amplification of stem cells
HUP0201887A2 (en) Conditioned cell culture medium compositions and methods of use
AU6340600A (en) Telomerase inhibitors and methods of their use
AU9582398A (en) Methods and devices for the long-term culture of hematopoietic progenitor cells
AU1478000A (en) (in utero) transplantation of human mesenchymal stem cells
AU1047901A (en) Methods of genetic cluster analysis and use thereof
AU1741601A (en) Mesenchymal stem cells and/or progenitor cells, their isolation and use
AU4829400A (en) Battery grid and method of making
AU2786100A (en) Method of selecting transformed cells and tissues
AU2998300A (en) Genetically altered mesenchymal stem cells and methods of use thereof
AU4520101A (en) Lung stem cells and lung regeneration
AU2002230459A1 (en) Cell culture apparatus and methods of use
AU6091600A (en) Mammalian cells expressing desaturases and elongases
AU2148200A (en) Titanium-indiffusion waveguides and methods of fabrication
AU2295201A (en) Spore-like cells and uses thereof
AU4774200A (en) Long term cell culture of human carcinoma
GB0318107D0 (en) ›-Secretase enzyme compositions and methods
AU2002230479A1 (en) Cell culture apparatus and methods of use

Legal Events

Date Code Title Description
MK13 Application withdrawn section 141(2)/reg 8.3(2) - pct appl. non-entering nat. phase, withdrawn by applicant